These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27536069)

  • 1. Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome.
    Kiałka M; Milewicz T; Sztefko K; Rogatko I; Majewska R
    Drug Des Devel Ther; 2016; 10():2483-90. PubMed ID: 27536069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressure pain threshold and β-endorphins plasma level are higher in lean polycystic ovary syndrome women.
    Kiałka M; Milewicz T; Mrozińska S; Rogatko I; Sztefko K; Majewska R
    Minerva Endocrinol; 2017 Dec; 42(4):297-305. PubMed ID: 27603705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
    Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metformin and changes in blood pressure and heart rate in lean patients with polycystic ovary syndrome (PCOS)--preliminary study].
    Tomczyk R; Ociepka A; Kiałka M; Milewicz T; Migacz K; Kowalczuk A; Klocek M
    Przegl Lek; 2015; 72(6):302-5. PubMed ID: 26817338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS)--the effect of metformin treatment.
    Kruszyńska A; Słowińska-Srzednicka J; Jeske W; Zgliczyński W
    Endokrynol Pol; 2014; 65(1):2-10. PubMed ID: 24549596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
    Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study.
    Stefanaki C; Bacopoulou F; Kandaraki E; Boschiero D; Diamandi-Kandarakis E
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31480705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin.
    Shigiyama F; Kumashiro N; Rikitake T; Usui S; Saegusa M; Kitamura M; Uchino H; Hirose T
    Endocr J; 2016; 63(2):193-8. PubMed ID: 26765270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
    Luque-Ramírez M; Alvarez-Blasco F; Uriol Rivera MG; Escobar-Morreale HF
    Hum Reprod; 2008 Jul; 23(7):1594-601. PubMed ID: 18375410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin monotherapy in lean women with polycystic ovary syndrome.
    Kumari AS; Haq A; Jayasundaram R; Abdel-Wareth LO; Al Haija SA; Alvares M
    Reprod Biomed Online; 2005 Jan; 10(1):100-4. PubMed ID: 15705302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
    Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment.
    Cheng F; Zhao L; Wu Y; Huang T; Yang G; Zhang Z; Wu Y; Jia F; Wu J; Chen C; Liu D
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):386-93. PubMed ID: 26387747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism.
    Morteza Taghavi S; Rokni H; Fatemi S
    Diab Vasc Dis Res; 2011 Jan; 8(1):47-8. PubMed ID: 21262871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.